Three Chinese Biotechs Ride Market Recovery To Raise Funds

 
• By Dexter Jie Yan

InventisBio and Akeso seek to gross a combined $384.3m in an initial public share sale in Shanghai and a private placement in Hong Kong respectively, while Chipscreen completed raising $74.4m by selling convertible bonds in Shanghai.

fund raising
Deal-making picks up pace as bio-sector stock index rebounds • Source: Alamy

More from Business

More from Scrip